Serological study of Human Parvovirus (B19) detected among Patients with Thalassemia

Main Article Content

Ahmed Waleed Dheyab Alnassar
Mohammed Jasim Mohammed Shallal


HPV: Human Parvovirus B19, β-thalassemia major


Background: Parvovirus B19 is an icosahedral, single-strand DNA, non-enveloped virus. Its DNA genome has 5596 bases and is from the Parvoviridae family. Beta thalassemia, a hereditary illness, causes ruptured red blood cells and acute anemia due to aberrant haemoglobin synthesis.
Aim: Detect parvovirus (B19) in β-thalassemia major and study its association with demographic factors like sex, age, place of residence, etc. in specific patient groups.
Methods: From August 2022 to the end of February 2023. This study included the collection of serum samples for the detection of human parvovirus antigen in 60 patients with β-thalassemia major. The control group consisted of 30 individuals of different ages who did not have thalassemia-beta. All these serum samples are detected for parvovirus antigen by the ELISA method.
Results: The results of this study showed that the rate of detection of the presence of human parvovirus B19 in the group of patients with β-thalassemia major was not affected by most of the demographic factors. As there were no statistically significant differences between the study groups in terms of gender, age, in addition to COVID-19 infection, and vaccination against COVID-19. However, the rate of β-thalassemia major was significantly higher in rural areas than in urban areas (p = 0.040).

Abstract 193 | pdf Downloads 159


1. Xu, Man, et al. Prevalence, cell tropism, and clinical impact of human parvovirus persistence in adenomatous, cancerous, inflamed, and healthy intestinal mucosa. Frontiers in Microbiology. 2022; 13(5):1–13.
2. Yousuf, Amjad. Human parvovirus B19 sero-molecular prevalence in Madinah blood donors, Saudi Arabia. Medical Science. 2022; 25(113):1551-1557.
3. Juhl, David; Hennig, Holger. Parvovirus B19: what is the relevance in transfusion medicine? Frontiers in Medicine. 2018, 5(4): 1-10.
4. Maisonneuve, Emeline, et al. Fetal brain injury associated with parvovirus B19 congenital infection requiring intrauterine transfusion. Fetal Diagnosis and Therapy. 2019; 46(1):1–11.
5. Teixeira, Ana Beatriz Gomes. O espectro das manifestações clínicas da infecção por Parvovírus B19. 2017. PhD Thesis.
6. Reggiani, Alessandro. A genome editing approach to the study of Parvovirus B19. 2022.
7. Sim, Jun Yi, et al. Human parvovirus B19 infection in patients with or without underlying diseases. Journal of Microbiology, Immunology and Infection. 2019; 52(4): 534-541.
8. Verdonschot, Job, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. European journal of heart failure. 2016; 18(12): 1430-1441.
9. Manaresi, Elisabetta; Gallinella, Giorgio. Advances in the development of antiviral strategies against parvovirus B19. Viruses. 2019; 11(7):2:1-21.
10. Xu, Peng, et al. Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway. PLoS pathogens. 2017; 13(3):1–28.
11. Manaresi, Elisabetta; Gallinella, Giorgio. Advances in the development of antiviral strategies against parvovirus B19. Viruses. 2019; 11(7):659.
12. Soltani, Saber, et al. A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients. Tropical Medicine and Health. 2020; 48(1): 1-8.
13. Jawetz, Melnick, Adelberg’s. Parvoviruses. In: MEDICAL MICROBIOLOGY. 28th edition. 2019. p. 460.
14. Sadah, Rand Rasid Abdul; AL-MARSOME, Huda Dhaher. Detection of Parvovirus B19 in B-thalassemia Major Patients by Serological and Molecular Method. Medico-Legal Update.2020; 20(4):2187-2191.
15. Fanoos HK. The Role of Parvovirus B19 in Thalassemia Patients in Thi- Qar Province. Thi-Qar; 2020.
16. Kishore, Janak; Srivastava, Manisha; Choudhury, Nabajyoti. Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units. Asian journal of transfusion science.2011; 5(2): 140.
17. Majeed, Hala Mohamed. Detection of Parvovirus B19 Infection in Thalasemic Patients in Tikrit City, Serological Study. Medico-legal Update. 2020; 20(1): 287-291.
18. Adnan H T, Seroprevalence of Human Parvovirus B19 Infection among Thalassemic Children in Babylon Center of Hereditary Blood Disorders. Medical Journal of Babylon .2013; 10(2):491-496.
19. Vilibic-Cavlek, Tatjana, et al. Parvovirus B19 in Croatia: A Large-Scale Seroprevalence Study. Medicina. 2021; 57(11): 1279.
20. Habibzadeh, Shahram, et al. The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013. Iranian journal of microbiology.2016; 8(3): 214.